Bioceres Crop Solutions Corp.
BIOX
$4.47
-$0.02-0.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -13.98% | -10.30% | 7.95% | 10.82% | 7.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.98% | -10.30% | 7.95% | 10.82% | 7.13% |
| Cost of Revenue | -14.16% | -10.72% | 11.59% | 17.54% | 13.52% |
| Gross Profit | -13.69% | -9.70% | 2.89% | 1.75% | -1.55% |
| SG&A Expenses | -2.80% | -2.46% | -4.60% | 2.47% | 5.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -54.47% | 32.44% | 131.15% | 184.81% | 184.36% |
| Total Operating Expenses | -11.85% | -6.55% | 9.01% | 15.72% | 14.22% |
| Operating Income | -38.14% | -38.55% | -1.68% | -23.05% | -37.18% |
| Income Before Tax | -259.32% | -117.21% | -39.23% | -47.48% | -54.41% |
| Income Tax Expenses | -252.48% | -423.08% | 136.86% | 453.57% | -15.86% |
| Earnings from Continuing Operations | -267.00% | -90.95% | -79.85% | -68.99% | -69.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 108.23% | 53.39% | -1,301.70% | -116.06% | 16.04% |
| Net Income | -395.47% | -93.16% | -89.29% | -82.73% | -80.18% |
| EBIT | -38.14% | -38.55% | -1.68% | -23.05% | -37.18% |
| EBITDA | -21.08% | -25.55% | 3.87% | -15.02% | -27.42% |
| EPS Basic | -397.93% | -93.27% | -89.46% | -82.97% | -78.04% |
| Normalized Basic EPS | -336.95% | -122.63% | -66.22% | -69.56% | -64.63% |
| EPS Diluted | -462.31% | -95.59% | -93.11% | -85.43% | -81.27% |
| Normalized Diluted EPS | -355.38% | -124.86% | -71.03% | -71.79% | -66.62% |
| Average Basic Shares Outstanding | 0.23% | 0.59% | 1.08% | 2.02% | 8.99% |
| Average Diluted Shares Outstanding | -1.18% | 1.84% | 3.03% | 3.49% | 10.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |